Directly Reprogrammed Human Neurons Retain Aging-Associated Transcriptomic Signatures and Reveal Age-Related Nucleocytoplasmic Defects.
- Authors
- Mertens, Jerome; Paquola, ApuΓ£ C M; Ku, Manching; Hatch, Emily; BΓΆhnke, Lena; Ladjevardi, Shauheen; McGrath, Sean; Campbell, Benjamin; Lee, Hyungjun; Herdy, Joseph R; GonΓ§alves, J Tiago; Toda, Tomohisa; Kim, Yongsung; Winkler, JΓΌrgen; Yao, Jun; Hetzer, Martin W; Gage, Fred H
- Year
- 2015
- Journal
- Cell stem cell
- PMID
- 26456686
- DOI
- 10.1016/j.stem.2015.09.001
- PMCID
- PMC5929130
Aging is a major risk factor for many human diseases, and in vitro generation of human neurons is an attractive approach for modeling aging-related brain disorders. However, modeling aging in differentiated human neurons has proved challenging. We generated neurons from human donors across a broad range of ages, either by iPSC-based reprogramming and differentiation or by direct conversion into induced neurons (iNs). While iPSCs and derived neurons did not retain aging-associated gene signatures, iNs displayed age-specific transcriptional profiles and revealed age-associated decreases in the nuclear transport receptor RanBP17. We detected an age-dependent loss of nucleocytoplasmic compartmentalization (NCC) in donor fibroblasts and corresponding iNs and found that reduced RanBP17 impaired NCC in young cells, while iPSC rejuvenation restored NCC in aged cells. These results show that iNs retain important aging-related signatures, thus allowing modeling of the aging process in vitro, and they identify impaired NCC as an important factor in human aging.
Age-Dependent Transcriptome Signatures in Fibroblasts and Derived iPSCs(A) iPSC reprogramming of young and old donor fibroblasts using the four Yamanaka-factors (4YF).(B) Phase contrast images and immunocytochemical characterization of human iPSCs stained with Nanog. The scale bars represent 20 ΞΌm.(C) Representative image for karyotype analysis of iPSC clones with G-banding (all included lines tested normal).(D) Differentially expressed genes between fibroblasts and iPSCs. The top 100 up and downregulated genes are shown (extended data in Table S2).(E) Heatmap showing hierarchical clustering of transcriptome similarity of fibroblasts and derived iPSCs. The black bars indicate multiple iPSC clones from the same donor that cluster together, and the * indicates lines from the same donor that do not cluster together.(F and G) MA plot shows differential expression between young (<40 year) and old (>40 year) fibroblasts and iPSCs (one clone per donor used for analysis). The colored dots indicate significant aging genes (padj < 0.05) (extended data in Table S3).
Direct Conversion of Young and Old Human Fibroblasts into Functional iNs Is Efficient Regardless of Donor Age(A) Direct iN conversion of young and old donor fibroblasts using Ngn2-2A-Ascl1 (N2A) and small molecular enhancers (SM).(B) Schematic of lentiviral system for inducible overexpression of N2A and SM for iN conversion.(C) Phase contrast images of progressively converting fibroblasts, and immunofluorescence images of 6-week converted fibroblasts stained with Ξ²III-tubulin, hTau, NeuN, Map2ab, and vGlut1.(D) iNs co-cultured on astrocytes labeled with LV-hSynβ·RFP and stained for synapsin-I following 8 weeks of conversion.(E) Electrophysiological characterization of iNs shows multiple evoked and spontaneous action potentials.(F) Immunocytochemical characterization of iN from young and old donors after 3 weeks of conversion. All of the scale bars represent 20 ΞΌM.(G) Quantification of neuronal yields per DAPI from 18 donors following 3 weeks of conversion. The bar graphs show mean + SEM.(H) Electrophysiological characterization of young- and old-derived iNs shows Na+/K+ channel-mediated inward/outward currents in response to depolarizing voltage steps (upper) and multiple evoked action potentials (lower) without apparent differences between young and old (n = 13 donors).(I) Quantification of neuronal subtype markers based on immunocytochemical analysis (extended data in Figure S2).Also see related Figure S1.
FACS-Based Purification and Transcriptome Analysis of iNs(A) Immunocytochemical staining of iNs with PSA-NCAM shows punctate staining on the surface of neurons.(B) Density plot of PSA-NCAM-stained iN cultures during FACSorting.(C) Quantification of Ξ²III-tubulin and hTau-positive neurons over human nuclei (hNuc) 1 week after FACS purification and replating. The bar graphs showmean + SEM.(D) Immunocytochemical analysis of 3-week-old sorted neurons following a total of 8 weeks of conversion stained with Ξ²III-tubulin, hTau, and human nuclei (hNuc). The scale bars represent 20 ΞΌm.(E) Heatmap of time course RNA-seq expression analysis of progressively converting iN cells and FACS-purified iNs (extended data in Table S4).(F) GO term analysis of the 200 most strongly (fold change) upregulated genes following 18 days of iN conversion (extended data in Table S5).(G)Gene expressionanalysis before andafterPSA-NCAMFACSpurification. The bars show normalized counts of day 18bulk (white) and day 18sorted (black) samples.Also see related Figure S2.
Age-Dependent Gene Expression in Human Fibroblasts and iNs(A) Heatmap showing hierarchical clustering of transcriptome similarity of fibroblasts and derived iNs. The black bars indicate multiple independent conversions from the same donor.(B and C) Heatmaps of significantly differentially expressed genes between young (<40 year) and old (>40 year) FACS-purified fibroblasts (red; 78 genes) and iNs (blue; 202 genes) with an FDR-adjusted p value < 0.05 (extended data in Table S3).(D) Schematic Venn diagram showing the overlap of fibroblast and iN aging genes.(E and F) GO term and KEGG pathway analysis of the 78 fibroblast and 202 iN aging genes (extended data in Table S6).Also see related Figure S3.
Expression of RanBP17 in the Aging Human Prefrontal Cortex(A) Schematic Venn diagram showing the overlap of postmortem cortex, fibroblast, and iN aging genes.(B) Correlation of RanBP17 expression with age in fibroblasts (red), purified iNs (blue), and RNA extracted from the human prefrontal cortex (green, n = 14 donors; Table S1). The data points indicate single donors, and the lines depict linear regression function (expression values: VST normalized counts).(C) Immunocytochemical analysis of subcellular RanBP17 localization in fibroblasts (upper) and iNs (lower) co-stained with hTau and Lamin B1. The scale bars represent 10 ΞΌm.(D) Formalin-fixed human cortices were embedded in paraffin and sectioned for immunohistochemistry to identify cortical neurons and layers. The Ξ²III-tubulin-positive cortical neurons were brightly stained in cortices from young adult and old brains (look-up-table, LUT, colored; numbers indicate cortical layer structure).(E) Immunohistochemical analysis of young adult and old brains for Ξ²III-tubulin and age-dependent decrease in RanBP17 in neurons. The scale bar represents 20 ΞΌm.(F) Representative images of RanBP17-stained cortical neurons show loss of RanBP17 from the neuronal somata and nuclei in old brains.(G) Quantification of neuronal fluorescence intensity comparing young and old brains (n = 10 donors). The bar graph shows means and dots individual cells (significance values: ****p < 0.001).(H) Quantification of western blot analysis for RanB17 protein over actin. The graph shows a correlation of cortical RanBP17 over actin with age. The dots indicate values of single donors Β± SEM, and the line depicts linear regression.Also see related Figures S4 and S5.
NCC in Young and Old Fibroblasts and Age-Equivalent iNs(A) 2Gi2R: lentiviral vector for expression of the IRES-linked NCC reporters 2xGFP:NES and 2xRFP:NLS. The experimental rationale for NCC measurement is that increasing GFPnuc/RFPnuc ratios indicate NCC defects and RFPnuc/RFPcyt and GFPnuc/GFPcyt ratios divide into import- or export-related phenotypes, respectively.(B) ROI selection of confocal sections for the measurement of nuclear GFP and RFP in cultured fibroblasts.(C) Representative florescence images of 2Gi2R reporter fibroblasts from a young adult (29 year) and old (69 year) donor. The scale bars represent 20 ΞΌm.(D)GFPnuc/RFPnuc, ratios in aging fibroblasts (n = 16 donors; normalized to young group). The bar graphs show mean + SEM and the dots indicate single cells (significance values: *p < 0.05; **p < 0.01; ***p < 0.005; and ****p < 0.001).(E) Correlation of NCC values of individual donors with age (black dots). The red line depicts linear regression fit, and the shaded area is the 95% confidence interval.(F) Experimental design: 3-week-old iNs were transduced with NCC reporter virus and relocated on a layer of astrocytes for maturation.(G) NCC was assessed by measuring neuronal GFPnuc/RFPnuc ratios in confocal sections.(H) GFPnuc/RFPnuc ratios in aging iNs (n = 14 donors). The data is normalized to the young group. The bar graphs show mean, and the dots indicate single cells (significance values: *p < 0.05; **p < 0.01; ***p < 0.005; and ****p < 0.001).(I) Correlation of NCC values of individual donors with age (black dots). The blue line depicts linear regression fit, and the shaded area is the 95% confidence interval.Also see related Figure S6.
RanBP17 Decrease Causes Loss of NCC and iPSC Reprogramming Restores NCC in Old Donor-Derived Cells(A) Lentiviral vector for RanBP17 knockdown (shRNAs: iR#1 and iR#2).(B) Western immunoblotting for RanBP17 in cells expressing iR#1, iR#2, or scrambled control shRNA.(C) qPCR analysis for iR#1 and iR#2 compared to scrambled control.(D) GFPnuc/RFPnuc ratios in young (1 year, left) and old (71 year, right) RanBP17 knockdown cells. The bar graphs show mean, and the dots indicate single cells (significance values: *p < 0.05; **p < 0.01; ***p < 0.005, and ****p < 0.001).(E) Fibroblast aging genes in response to RanBP17 knockdown. The graph shows expression changes (old versus young) of the 78 fibroblast aging genes in response to aging (black bars) and in response to RanBP17 knockdown in young fibroblasts (1 year). The RanBP17 knockdown caused 68% of the aging genes to change in the same direction as in aging.(F) RanBP17 mRNA levels in fibroblasts (red) and corresponding iPSCs (green; VST normalized counts).(G) Monolayer PluriPro culture of iPSCs for the measurement of NCC.(H) GFPnuc/RFPnuc ratios in iPSCs reprogrammed from young and old donors (n = 12 donors). The bars represent means, and the dots represent individual cells.(I) Correlation of NCC with donor age in iPSCs. The black dots represent individual donor iPSCs. The green line represents the linear regression fit, and the shaded area is the 95% confidence interval.Also see related Figure S7.
No entities extracted from this document yet.
No uploaded files.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Deep Profiling of the Aging Proteome Depicts Neuroinflammation, Synaptic Function, and Phosphorylation in an Accelerated Alzheimer's Disease Cell Model. | Gentry E et al. | β | 2026 | β |
| Directed differentiation of human mesenchymal stromal cells into functional endothelial cells having IKAROS-mediated immune tolerance properties. | Han JK et al. | β | 2026 | β |
| Epigenetic aging and rejuvenation of the brain: drivers, consequences, and interventions. | Lee S et al. | β | 2026 | β |
| Experimental Models to Study Polyglutamine Spinocerebellar Ataxias: From Mechanisms to Therapeutic Developments. | Ruiz-Esparza-Palacios V et al. | β | 2026 | β |
| From Dish to Trial: Building Translational Models of ALS. | Salamotas I et al. | β | 2026 | β |
| Impaired nucleocytoplasmic transport in SOD1-mediated ALS. | Argueti-Ostrovsky S et al. | β | 2026 | β |
| Introducing Cellular Senescence in Human Induced Pluripotent Stem Cells and Differentiated Neural Lineage for Modeling of Age-Associated Diseases. | Neherin K et al. | β | 2026 | β |
| Molecular characterization of directly reprogrammed neurons from human fibroblasts using single cell RNA sequencing. | Seo DJ et al. | β | 2026 | β |
| Quantifying the Single-Cell Morphological Landscape of Cellular Transdifferentiation through Force Field Reconstruction. | Yu C et al. | β | 2026 | β |
| Skin Organoids in Proteostasis Research: Early Insights into Aging. | Hossain MK et al. | β | 2026 | β |
| The application of directly induced neurons into neurodegenerative disease modeling. | Matsumoto K et al. | β | 2026 | β |
| Transcriptional signature of induced neurons differentiates virologically suppressed people with HIV from people without HIV. | Ostermann PN et al. | β | 2026 | β |
| Advances, challenges, and opportunities of human midbrain organoids for modelling of the dopaminergic system. | Fiorenzano A et al. | β | 2025 | β |
| Alpha-lipoic acid supplementation improves pathological alterations in cellular models of Friedreich ataxia. | TalaverΓ³n-Rey M et al. | β | 2025 | β |
| Assessing <i>in-vitro</i> models for microglial development and fetal programming: a critical review. | Schepanski S et al. | β | 2025 | β |
| AΞ²-driven nuclear pore complex dysfunction alters activation of necroptosis proteins in a mouse model of Alzheimer's disease. | Bansal VA et al. | β | 2025 | β |
| Blocking nuclear receptor Nr4a3 unlocks the senescence barrier to promote direct cardiac reprogramming. | Liu M et al. | β | 2025 | β |
| Brain aging and rejuvenation at single-cell resolution. | Sun ED et al. | β | 2025 | β |
| Cell reprogramming: methods, mechanisms and applications. | Zhu F et al. | β | 2025 | β |
| Cellular Models of Aging and Senescence. | Kim B et al. | β | 2025 | β |
| Compact transcription factor cassettes generate functional, engraftable motor neurons by direct conversion. | Wang NB et al. | β | 2025 | β |
| CRISPRi-based screens in iAssembloids to elucidate neuron-glia interactions. | Li E et al. | β | 2025 | β |
| Current Development of iPSC-Based Modeling in Neurodegenerative Diseases. | Guo X et al. | β | 2025 | β |
| Detecting the Undetectable: Advances in Methods for Identifying Small Tau Aggregates in Neurodegenerative Diseases. | BΓΆken D et al. | β | 2025 | β |
| Elevated p16Ink4a Expression Enhances Tau Phosphorylation in Neurons Differentiated From Human-Induced Pluripotent Stem Cells. | Holloway K et al. | β | 2025 | β |
| Fate erasure logic of gene networks underlying direct neuronal conversion of somatic cells by microRNAs. | Cates K et al. | β | 2025 | β |
| From in vivo models to in vitro bioengineered neuromuscular junctions for the study of Charcot-Marie-Tooth disease. | Scherrer C et al. | β | 2025 | β |
| Human induced pluripotent stem cell models for Alzheimer's disease research: a bibliometric analysis. | Sun Y et al. | β | 2025 | β |
| Identifying Age-Modulating Compounds Using a Novel Computational Framework for Evaluating Transcriptional Age. | Zhang C et al. | β | 2025 | β |
| Identifying key regulators in neuronal transdifferentiation by gene regulatory network analysis. | Li L et al. | β | 2025 | β |
| Increasing hexokinase 1 expression improves mitochondrial and glycolytic functional deficits seen in sporadic Alzheimer's disease astrocytes. | Bell SM et al. | β | 2025 | β |
| Investigating the ageing-Parkinson's disease nexus: standardisation of in vitro models and techniques by the PD-AGE network. | Bury AG et al. | β | 2025 | β |
| In vitro modelling of the neuropathophysiological features of mitochondrial epilepsy. | Smith LA et al. | β | 2025 | β |
| Long-lived cellular molecules in the brain. | Hetzer MW et al. | β | 2025 | β |
| Monitoring Autophagy in Human Aging: Key Cell Models and Insights. | Moreno TM et al. | β | 2025 | β |
| Navigating the neuronal recycling bin: Another look at huntingtin in coordinating autophagy. | Krzystek TJ et al. | β | 2025 | β |
| Neuronal aging causes mislocalization of splicing proteins and unchecked cellular stress. | Rhine K et al. | β | 2025 | β |
| Nuclear envelope components in vascular mechanotransduction: emerging roles in vascular health and disease. | Nguyen TD et al. | β | 2025 | β |
| Nuclear Import Defects Drive Cell Cycle Dysregulation in Neurodegeneration. | Plessis-Belair J et al. | β | 2025 | β |
| Nuclear translocation of the LINE-1 encoded ORF1 protein alters nuclear envelope integrity in human neurons. | Znaidi R et al. | β | 2025 | β |
| Proteostasis and lysosomal repair deficits in transdifferentiated neurons of Alzheimer's disease. | Chou CC et al. | β | 2025 | β |
| PTBP1 depletion in mature astrocytes reveals distinct splicing alterations without neuronal features. | Zhang M et al. | β | 2025 | β |
| Reprogramming Stars #25: Modeling Brain Aging with Direct Reprogramming of Skin Cells into Neurons-An Interview with Dr. Jerome Mertens. | Mertens J et al. | β | 2025 | β |
| Research models to study lewy body dementia. | Boschen SL et al. | β | 2025 | β |
| RNA dysregulation impairs stress resilience in aged neurons. | β | β | 2025 | β |
| Somatic and Stem Cell Bank to study the contribution of African ancestry to dementia: African iPSC Initiative. | Maina MB et al. | β | 2025 | β |
| Somatic cell reprogramming for Parkinson's disease treatment. | Li X et al. | β | 2025 | β |
| Structural basis for a nucleoporin exportin complex between RanBP2, SUMO1-RanGAP1, the E2 Ubc9, Crm1 and the Ran GTPase. | Baytshtok V et al. | β | 2025 | β |
| Sustaining Brain Youth by Neural Stem Cells: Physiological and Therapeutic Perspectives. | Santos M et al. | β | 2025 | β |
| Targeting common disease pathomechanisms to treat amyotrophic lateral sclerosis. | Faller KME et al. | β | 2025 | β |
| The complex web of membrane contact sites in brain aging and neurodegeneration. | Azarnia Tehran D et al. | β | 2025 | β |
| The leader proteins of Theiler's virus and Boone cardiovirus use a combination of short linear motifs (SLiMs) to target RSK kinases to the nuclear pore complex. | Lizcano-Perret B et al. | β | 2025 | β |
| Three-dimensional cell-cell interactions promote direct reprogramming of patient fibroblasts into functional and transplantable neurons. | Kajtez J et al. | β | 2025 | β |
| Tracing mitochondrial marks of neuronal aging in iPSCs-derived neurons and directly converted neurons. | Varghese N et al. | β | 2025 | β |
| Transcriptional impacts of substance use disorder and HIV on human ventral midbrain neurons and microglia. | Wilson AM et al. | β | 2025 | β |
| Transcriptome signatures of human neural stem cells derived from LRRK2 gene therapeutic cells. | Kim D et al. | β | 2025 | β |
| Transformative advances in modeling brain aging and longevity: Success, challenges and future directions. | Pai V et al. | β | 2025 | β |
| A cellular identity crisis? Plasticity changes during aging and rejuvenation. | Gorelov R et al. | β | 2024 | β |
| A framework for translating tauopathy therapeutics: Drug discovery to clinical trials. | Feldman HH et al. | β | 2024 | β |
| Age- and disease-related autophagy impairment in Huntington disease: New insights from direct neuronal reprogramming. | Luo C et al. | β | 2024 | β |
| AΞ²-driven nuclear pore complex dysfunction alters activation of necroptosis proteins in a mouse model of Alzheimerβs Disease | Bansal VA et al. | β | 2024 | β |
| Cellular plasticity in reprogramming, rejuvenation and tumorigenesis: a pioneer TF perspective. | Huyghe A et al. | β | 2024 | β |
| Cellular reprogramming as a tool to model human aging in a dish. | Pitrez PR et al. | β | 2024 | β |
| Dedifferentiation-like reprogramming of degenerative nucleus pulposus cells into notochordal-like cells by defined factors. | Zhang Y et al. | β | 2024 | β |
| Direct conversion of urine-derived cells into functional motor neuron-like cells by defined transcription factors. | Nagai H et al. | β | 2024 | β |
| Direct Reprogramming of Somatic Skin Cells from a Patient with Huntington's Disease into Striatal Neurons to Create Models of Pathology. | Kraskovskaya NA et al. | β | 2024 | β |
| Disease phenotypic screening in neuron-glia cocultures identifies blockers of inflammatory neurodegeneration. | Birkle TJY et al. | β | 2024 | β |
| Disentangling tau: One protein, many therapeutic approaches. | Lane-Donovan C et al. | β | 2024 | β |
| Elevated expression of the retrotransposonΒ LINE-1Β drives Alzheimer's disease-associated microglial dysfunction. | Roy N et al. | β | 2024 | β |
| From Young to Old: Mimicking Neuronal Aging in Directly Converted Neurons from Young Donors. | Varghese N et al. | β | 2024 | β |
| Generation and Characterization of a Human Neuronal In Vitro Model for Rett Syndrome Using a Direct Reprogramming Method. | Huber A et al. | β | 2024 | β |
| Genome-wide CRISPR screen identifies neddylation as a regulator of neuronal aging and AD neurodegeneration. | Saurat N et al. | β | 2024 | β |
| Human iN neuronal model of schizophrenia displays dysregulation of chromogranin B and related neuropeptide transmitter signatures. | Podvin S et al. | β | 2024 | β |
| Human iPSCs from Aged Donors Retain Their Mitochondrial Aging Signature. | Lejri I et al. | β | 2024 | β |
| Human stem cell-based models to study synaptic dysfunction and cognition in schizophrenia: A narrative review. | Santarriaga S et al. | β | 2024 | β |
| Impact of ageing and disuse on neuromuscular junction and mitochondrial function and morphology: Current evidence and controversies. | Motanova E et al. | β | 2024 | β |
| In vitro human cell culture models in a bench-to-bedside approach to epilepsy. | DanaΔΓkovΓ‘ Ε et al. | β | 2024 | β |
| KCNJ2 inhibition mitigates mechanical injury in a human brain organoid model of traumatic brain injury. | Lai JD et al. | β | 2024 | β |
| KMT2A regulates the autophagy-GATA4 axis through METTL3-mediated m<sup>6</sup>A modification of ATG4a to promote NPCs senescence and IVDD progression. | Wu O et al. | β | 2024 | β |
| Late onset Alzheimer's disease: modeling disease hallmarks via in vitro 3D iNeuron cultures. | Masserdotti G | β | 2024 | β |
| Lessons from inducible pluripotent stem cell models on neuronal senescence in aging and neurodegeneration. | de Luzy IR et al. | β | 2024 | β |
| Lineage Reprogramming: Genetic, Chemical, and Physical Cues for Cell Fate Conversion with a Focus on Neuronal Direct Reprogramming and Pluripotency Reprogramming. | Umeyama T et al. | β | 2024 | β |
| Machine learning-based morphological quantification of replicative senescence in human fibroblasts. | Welter EM et al. | β | 2024 | β |
| Mapping the future of oxidative RNA damage in neurodegeneration: Rethinking the status quo with new tools. | Wheeler HB et al. | β | 2024 | β |
| Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming. | Cipriano A et al. | β | 2024 | β |
| Microglia contribute to the production of the amyloidogenic ABri peptide in familial British dementia. | Arber C et al. | β | 2024 | β |
| Modeling late-onset Alzheimer's disease neuropathology via direct neuronal reprogramming. | Sun Z et al. | β | 2024 | β |
| Molecular and cellular mechanisms of selective vulnerability in neurodegenerative diseases. | Kampmann M | β | 2024 | β |
| Neuronal conversion from glia to replenish the lost neurons. | Liang S et al. | β | 2024 | β |
| Neuronal reprogramming of mouse and human fibroblasts using transcription factors involved in suprachiasmatic nucleus development. | Hirayama M et al. | β | 2024 | β |
| Next-generation direct reprogramming. | Keshri R et al. | β | 2024 | β |
| Novel Approaches to Studying SLC13A5 Disease. | Beltran AS | β | 2024 | β |
| Novel human iPSC models of neuroinflammation in neurodegenerative disease and regenerative medicine. | Summers RA et al. | β | 2024 | β |
| Nucleoporin93 limits Yap activity to prevent endothelial cell senescence. | Nguyen TD et al. | β | 2024 | β |
| Partial Reprogramming as a Method for Regenerating Neural Tissues in Aged Organisms. | Sichani AS et al. | β | 2024 | β |
| Partial Reprogramming Exerts a Rejuvenating Effect on Human Mesenchymal Stem Cells That Underwent Replicative Senescence in Culture. | Ivanova J et al. | β | 2024 | β |
| Patient-derived neuron model: Capturing age-dependent adult-onset degenerative pathology in Huntington's disease. | Oh YM et al. | β | 2024 | β |
| Physiological aging and inflammation-induced cellular senescence may contribute to oligodendroglial dysfunction in MS. | Windener F et al. | β | 2024 | β |
| Pros and Cons of Human Brain Organoids to Study Alzheimer's Disease. | Sainz A et al. | β | 2024 | β |
| RANBP17 Overexpression Restores Nucleocytoplasmic Transport and Ameliorates Neurodevelopment in Induced DYT1 Dystonia Motor Neurons. | Akter M et al. | β | 2024 | β |
| Restoring hippocampal glucose metabolism rescues cognition across Alzheimer's disease pathologies. | Minhas PS et al. | β | 2024 | β |
| RNA variant assessment using transactivation and transdifferentiation. | Nicolas-Martinez EC et al. | β | 2024 | β |
| Screens in aging-relevant human ALS-motor neurons identify MAP4Ks as therapeutic targets for the disease. | Liu ML et al. | β | 2024 | β |
| Short Peptides Protect Fibroblast-Derived Induced Neurons from Age-Related Changes. | Kraskovskaya N et al. | β | 2024 | β |
| SUN1 facilitates CHMP7 nuclear influx and injury cascades in sporadic amyotrophic lateral sclerosis. | Baskerville V et al. | β | 2024 | β |
| Tackling neurodegeneration <i>in vitro</i> with omics: a path towards new targets and drugs. | Carraro C et al. | β | 2024 | β |
| Telomere shortening induces aging-associated phenotypes in hiPSC-derived neurons and astrocytes. | Harley J et al. | β | 2024 | β |
| The anti-leprosy drug clofazimine reduces polyQ toxicity through activation of PPARΞ³. | Li X et al. | β | 2024 | β |
| The evolution of <i>in vitro</i> models of lung fibrosis: promising prospects for drug discovery. | Kolanko E et al. | β | 2024 | β |
| The impact of aging on cardiac repair and regeneration. | Anwar I et al. | β | 2024 | β |
| The impact of aging on HIV-1-related neurocognitive impairment. | Ostermann PN et al. | β | 2024 | β |
| The role of glial cells in amyotrophic lateral sclerosis. | Pandya VA et al. | β | 2024 | β |
| The silent protector: Nucleoporin93's role in vascular health. | Michalkiewicz J et al. | β | 2024 | β |
| Transcription Factors in Brain Regeneration: A Potential Novel Therapeutic Target. | Marzoog BA | β | 2024 | β |
| Upregulated ECM genes and increased synaptic activity in Parkinson's human DA neurons with PINK1/ PRKN mutations. | Tripathi U et al. | β | 2024 | β |
| Young Plasma Rejuvenates Blood DNA Methylation Profile, Extends Mean Lifespan, and Improves Physical Appearance in Old Rats. | Chiavellini P et al. | β | 2024 | β |
| Ξ²-Amyloid species production and tau phosphorylation in iPSC-neurons with reference to neuropathologically characterized matched donor brains. | Oakley DH et al. | β | 2024 | β |
| Alzheimer's disease and synapse Loss: What can we learn from induced pluripotent stem Cells? | Rodriguez-Jimenez FJ et al. | β | 2023 | β |
| A simple, flexible, and high-efficiency western blot analysis for age-related human induced neurons. | Shen YF et al. | β | 2023 | β |
| Cell reprogramming for oligodendrocytes: A review of protocols and their applications to disease modeling and cell-based remyelination therapies. | McCaughey-Chapman A et al. | β | 2023 | β |
| Cell Reprogramming Strategies for Treating Osteoarthritis and Intervertebral Disc Degeneration. | Jiang Z et al. | β | 2023 | β |
| Chemically induced reprogramming to reverse cellular aging. | Yang JH et al. | β | 2023 | β |
| Chromatin: the old and young of it. | Emerson FJ et al. | β | 2023 | β |
| Development of direct cardiac reprogramming for clinical applications. | Yamada Y et al. | β | 2023 | β |
| Direct Conversion of Fibroblast into Neurons for Alzheimer's Disease Research: A Systematic Review. | Sattarov R et al. | β | 2023 | β |
| Endothelial cell direct reprogramming: Past, present, and future. | Cho S et al. | β | 2023 | β |
| Engineering Materials and Devices for the Prevention, Diagnosis, and Treatment of COVID-19 and Infectious Diseases. | Soto J et al. | β | 2023 | β |
| Epigenetic rejuvenation by partial reprogramming. | Puri D et al. | β | 2023 | β |
| Fountain of youth-Targeting autophagy in aging. | Danics L et al. | β | 2023 | β |
| From cells to insights: the power of human pluripotent stem cell-derived cortical interneurons in psychiatric disorder modeling. | Ni P et al. | β | 2023 | β |
| Functional bioengineered tissue models of neurodegenerative diseases. | Mullis AS et al. | β | 2023 | β |
| High content screening miniaturization and single cell imaging of mature human feeder layer-free iPSC-derived neurons. | Sharlow ER et al. | β | 2023 | β |
| Human-Induced Pluripotent Stem Cell (hiPSC)-Derived Neurons and Glia for the Elucidation of Pathogenic Mechanisms in Alzheimer's Disease. | Young JE et al. | β | 2023 | β |
| Inflammation and aging: signaling pathways and intervention therapies. | Li X et al. | β | 2023 | β |
| Insights and applications of direct neuronal reprogramming. | Schaukowitch K et al. | β | 2023 | β |
| In Vitro Modeling as a Tool for Testing Therapeutics for Spinal Muscular Atrophy and IGHMBP2-Related Disorders. | Sierra-Delgado JA et al. | β | 2023 | β |
| Limitations of the human iPSC-derived neuron model for early-onset Alzheimer's disease. | Valdes P et al. | β | 2023 | β |
| Loss of C9orf72 perturbs the Ran-GTPase gradient and nucleocytoplasmic transport, generating compositionally diverse Importin Ξ²-1 granules. | McGoldrick P et al. | β | 2023 | β |
| Low glucose induced Alzheimer's disease-like biochemical changes in human induced pluripotent stem cell-derived neurons is due to dysregulated O-GlcNAcylation. | Huang CW et al. | β | 2023 | β |
| Moving CNS axon growth and regeneration research into human model systems. | Lear BP et al. | β | 2023 | β |
| Neural cell state shifts and fate loss in ageing and age-related diseases. | Traxler L et al. | β | 2023 | β |
| Nuclear import carrier Hikeshi cooperates with HSP70 to promote murine oligodendrocyte differentiation and CNS myelination. | Li L et al. | β | 2023 | β |
| Patient-Derived Cellular Models for Polytarget Precision Medicine in Pantothenate Kinase-Associated Neurodegeneration. | Γlvarez-CΓ³rdoba M et al. | β | 2023 | β |
| Pharmacological profiling identifies divergent chemosensitivities of differentiating and maturing iPSC-derived human cortical neuron populations. | Sharlow ER et al. | β | 2023 | β |
| Reprogramming of adult human dermal fibroblasts to induced dorsal forebrain precursor cells maintains aging signatures. | McCaughey-Chapman A et al. | β | 2023 | β |
| Retinal ganglion cell repopulation for vision restoration in optic neuropathy: a roadmap from the RReSTORe Consortium. | Soucy JR et al. | β | 2023 | β |
| Role of NCKAP1 in the Defective Phagocytic Function of Microglia-Like Cells Derived from Rapidly Progressing Sporadic ALS. | Noh MY et al. | β | 2023 | β |
| Spinal Cord Organoids to Study Motor Neuron Development and Disease. | Buchner F et al. | β | 2023 | β |
| Stem cell programmingΒ - prospects for perinatal medicine. | Berg LJ et al. | β | 2023 | β |
| Tau pathology in neurodegenerative disease: disease mechanisms and therapeutic avenues. | Samudra N et al. | β | 2023 | β |
| The development and benefits of metformin in various diseases. | Dong Y et al. | β | 2023 | β |
| The Information Theory of Aging. | Lu YR et al. | β | 2023 | β |
| The master energy homeostasis regulator PGC-1Ξ± exhibits an mRNA nuclear export function. | Mihaylov SR et al. | β | 2023 | β |
| The Nuclear Envelope in Ageing and Progeria. | Fragoso-Luna A et al. | β | 2023 | β |
| The Wisdom in Teeth: Neuronal Differentiation of Dental Pulp Cells. | SramkΓ³ B et al. | β | 2023 | β |
| Transcriptomic reprogramming for neuronal age reversal. | Plesa AM et al. | β | 2023 | β |
| Unraveling the impact of disrupted nucleocytoplasmic transport systems in <i>C9orf72</i>-associated ALS. | McGoldrick P et al. | β | 2023 | β |
| Use of <i>in vitro</i> derived human neuronal models to study host-parasite interactions of <i>Toxoplasma gondii</i> in neurons and neuropathogenesis of chronic toxoplasmosis. | Halonen SK | β | 2023 | β |
| Why should we care about astrocytes in a motor neuron disease? | Stoklund Dittlau K et al. | β | 2023 | β |
| Accelerated neuronal aging <i>in vitro</i> βΌmelting watch βΌ. | Inagaki E et al. | β | 2022 | β |
| Age-related Huntington's disease progression modeled in directly reprogrammed patient-derived striatal neurons highlights impaired autophagy. | Oh YM et al. | β | 2022 | β |
| Age-related pathological impairments in directly reprogrammed dopaminergic neurons derived from patients with idiopathic Parkinson's disease. | Drouin-Ouellet J et al. | β | 2022 | β |
| Amyotrophic lateral sclerosis (ALS) linked mutation in Ubiquilin 2 affects stress granule assembly via TIA-1. | Peng G et al. | β | 2022 | β |
| An Improved Method to Generate Human Induced Astrocytes. | Drouin-Ouellet J | β | 2022 | β |
| A Nuclear Belt Fastens on Neural Cell Fate. | Mestres I et al. | β | 2022 | β |
| Beyond Static Pipes: Mechanisms and In Vitro Models of Vascular Aging. | Hetzer MW et al. | β | 2022 | β |
| Brain aging, Alzheimer's disease, and the role of stem cells in primate comparative studies. | August I et al. | β | 2022 | β |
| Cardiovirus leader proteins retarget RSK kinases toward alternative substrates to perturb nucleocytoplasmic traffic. | Lizcano-Perret B et al. | β | 2022 | β |
| Cell models for Down syndrome-Alzheimer's disease research. | Wu Y et al. | β | 2022 | β |
| Chemically induced senescence in human stem cell-derived neurons promotes phenotypic presentation of neurodegeneration. | Fathi A et al. | β | 2022 | β |
| Chemical Replacement of Noggin with Dorsomorphin Homolog 1 for Cost-Effective Direct Neuronal Conversion. | BΓΆhnke L et al. | β | 2022 | β |
| Chemical reprogramming of human somatic cells to pluripotent stem cells. | Guan J et al. | β | 2022 | β |
| Detection of Pathological Markers of Neurodegenerative Diseases following Microfluidic Direct Conversion of Patient Fibroblasts into Neurons. | Mollinari C et al. | β | 2022 | β |
| Direct Conversion of Cell Fate and Induced Endothelial Cells. | Han JK et al. | β | 2022 | β |
| Direct neuronal reprogramming: Fast forward from new concepts toward therapeutic approaches. | Bocchi R et al. | β | 2022 | β |
| Diseased, differentiated and difficult: Strategies for improved engineering of <i>in vitro</i> neurological systems. | Elder N et al. | β | 2022 | β |
| Disease Modeling of Neurodegenerative Disorders Using Direct Neural Reprogramming. | Legault EM et al. | β | 2022 | β |
| Distinct subcellular autophagy impairments in induced neurons from patients with Huntington's disease. | Pircs K et al. | β | 2022 | β |
| Diverse partial reprogramming strategies restore youthful gene expression and transiently suppress cell identity. | Roux AE et al. | β | 2022 | β |
| Druggable transcriptomic pathways revealed in Parkinson's patient-derived midbrain neurons. | van den Hurk M et al. | β | 2022 | β |
| Dynamics of Metabolic Pathways and Stress Response Patterns during Human Neural Stem Cell Proliferation and Differentiation. | Semkova V et al. | β | 2022 | β |
| Endogenous <i>versus</i> exogenous cell replacement for Parkinson's disease: where are we at and where are we going? | Mourtzi T et al. | β | 2022 | β |
| Heat-shock chaperone HSPB1 regulates cytoplasmic TDP-43 phase separation and liquid-to-gel transition. | Lu S et al. | β | 2022 | β |
| Human Brain-Based Models Provide a Powerful Tool for the Advancement of Parkinson's Disease Research and Therapeutic Development. | McComish SF et al. | β | 2022 | β |
| Human-Induced Pluripotent Stem Cell-Based Models for Studying Sex-Specific Differences in Neurodegenerative Diseases. | Kiris E | β | 2022 | β |
| Human iPSC-Derived Neural Models for Studying Alzheimer's Disease: from Neural Stem Cells to Cerebral Organoids. | Barak M et al. | β | 2022 | β |
| Human stem cell models of neurodegeneration: From basic science of amyotrophic lateral sclerosis to clinical translation. | Giacomelli E et al. | β | 2022 | β |
| Increased post-mitotic senescence in aged human neurons is a pathological feature of Alzheimer's disease. | Herdy JR et al. | β | 2022 | β |
| Induced pluripotent stem cell-derived and directly reprogrammed neurons to study neurodegenerative diseases: The impact of aging signatures. | Aversano S et al. | β | 2022 | β |
| Karyopherin enrichment and compensation fortifies the nuclear pore complex against nucleocytoplasmic leakage. | Kalita J et al. | β | 2022 | β |
| Leaf cell-specific and single-cell transcriptional profiling reveals a role for the palisade layer in UV light protection. | Procko C et al. | β | 2022 | β |
| Leveraging the Genetic Diversity of Human Stem Cells in Therapeutic Approaches. | Tegtmeyer M et al. | β | 2022 | β |
| m6A hypomethylation of DNMT3B regulated by ALKBH5 promotes intervertebral disc degeneration via E4F1 deficiency. | Li G et al. | β | 2022 | β |
| Mitochondrial dysfunction of induced pluripotent stem cells-based neurodegenerative disease modeling and therapeutic strategy. | Luo HM et al. | β | 2022 | β |
| Modeling Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes Syndrome Using Patient-Derived Induced Neurons Generated by Direct Reprogramming. | Povea-Cabello S et al. | β | 2022 | β |
| Motor neuron-derived induced pluripotent stem cells as a drug screening platform for amyotrophic lateral sclerosis. | AmorΓ³s MA et al. | β | 2022 | β |
| Nontransgenic Guinea Pig Strains Exhibit Hallmarks of Human Brain Aging and Alzheimer's Disease. | Wahl D et al. | β | 2022 | β |
| Nuclear pore complexes - a doorway to neural injury in neurodegeneration. | Coyne AN et al. | β | 2022 | β |
| Optimization of Long-Term Human iPSC-Derived Spinal Motor Neuron Culture Using a Dendritic Polyglycerol Amine-Based Substrate. | Thiry L et al. | β | 2022 | β |
| Parkin Deficiency Impairs Mitochondrial DNA Dynamics and Propagates Inflammation. | Wasner K et al. | β | 2022 | β |
| Past, Present, and Future of Direct Cell Reprogramming. | Ahlenius H | β | 2022 | β |
| PolyGA targets the ER stress-adaptive response by impairing GRP75 function at the MAM in C9ORF72-ALS/FTD. | Pilotto F et al. | β | 2022 | β |
| Protocol to image and quantify nucleocytoplasmic transport in cultured cells using fluorescent <i>in situ</i> hybridization and a dual reporter system. | Cui H et al. | β | 2022 | β |
| Recapitulation of endogenous 4R tau expression and formation of insoluble tau in directly reprogrammed human neurons. | Capano LS et al. | β | 2022 | β |
| Reduced synaptic activity and dysregulated extracellular matrix pathways in midbrain neurons from Parkinson's disease patients. | Stern S et al. | β | 2022 | β |
| Somatic Lineage Reprogramming. | Shelby H et al. | β | 2022 | β |
| The importin beta superfamily member RanBP17 exhibits a role in cell proliferation and is associated with improved survival of patients with HPV+βHNSCC. | Mandic R et al. | β | 2022 | β |
| Therapeutic Antiaging Strategies. | Mishra SK et al. | β | 2022 | β |
| Towards elucidating disease-relevant states of neurons and glia by CRISPR-based functional genomics. | Leng K et al. | β | 2022 | β |
| Transcriptional dynamics of murine motor neuron maturation in vivo and in vitro. | Patel T et al. | β | 2022 | β |
| Transcription factor-based direct conversion of human fibroblasts to functional astrocytes. | Quist E et al. | β | 2022 | β |
| Transgene and Chemical Transdifferentiation of Somatic Cells for Rapid and Efficient Neurological Disease Cell Models. | Ng N et al. | β | 2022 | β |
| Uncovering specificity of endogenous TAU aggregation in a human iPSC-neuron TAU seeding model. | Manos JD et al. | β | 2022 | β |
| Warburg-like metabolic transformation underlies neuronal degeneration in sporadic Alzheimer's disease. | Traxler L et al. | β | 2022 | β |
| WTAP-mediated m<sup>6</sup>A modification of lncRNA NORAD promotes intervertebral disc degeneration. | Li G et al. | β | 2022 | β |
| Advancing models of neural development with biomaterials. | Roth JG et al. | β | 2021 | β |
| Age-dependent instability of mature neuronal fate in induced neurons from Alzheimer's patients. | Mertens J et al. | β | 2021 | β |
| Aged Microglia in Neurodegenerative Diseases: Microglia Lifespan and Culture Methods. | Yoo HJ et al. | β | 2021 | β |
| Aging and rejuvenation - a modular epigenome model. | Chiavellini P et al. | β | 2021 | β |
| Aging, Bone Marrow and Next-Generation Sequencing (NGS): Recent Advances and Future Perspectives. | Ganguly P et al. | β | 2021 | β |
| Aging Induces Hepatic Oxidative Stress and Nuclear Proteomic Remodeling in Liver from Wistar Rats. | BΓ‘rcena B et al. | β | 2021 | β |
| A Non-Toxic Concentration of Telomerase Inhibitor BIBR1532 Fails to Reduce <i>TERT</i> Expression in a Feeder-Free Induced Pluripotent Stem Cell Model of Human Motor Neurogenesis. | Pandya VA et al. | β | 2021 | β |
| ApoE-Isoform-Dependent SARS-CoV-2 Neurotropism and Cellular Response. | Wang C et al. | β | 2021 | β |
| A quantitative model of cellular decision making in direct neuronal reprogramming. | Merlevede A et al. | β | 2021 | β |
| Astrocytes and microglia in neurodegenerative diseases: Lessons from human in vitro models. | Franklin H et al. | β | 2021 | β |
| Bcl-2-Assisted Reprogramming of Mouse Astrocytes and Human Fibroblasts into Induced Neurons. | Falco A et al. | β | 2021 | β |
| Cell Reprogramming to Model Huntington's Disease: A Comprehensive Review. | Monk R et al. | β | 2021 | β |
| Cellular complexity in brain organoids: Current progress and unsolved issues. | Mansour AA et al. | β | 2021 | β |
| Cellular Models and High-Throughput Screening for Genetic Causality of Intellectual Disability. | Fell CW et al. | β | 2021 | β |
| Characterization of DNA Methylomic Signatures in Induced Pluripotent Stem Cells During Neuronal Differentiation. | Imm J et al. | β | 2021 | β |
| Deconstructing Alzheimer's Disease: How to Bridge the Gap between Experimental Models and the Human Pathology? | Vignon A et al. | β | 2021 | β |
| Deconstructing Stepwise Fate Conversion of Human Fibroblasts to Neurons by MicroRNAs. | Cates K et al. | β | 2021 | β |
| Development of a physiologically relevant and easily scalable LUHMES cell-based model of G2019S LRRK2-driven Parkinson's disease. | Calamini B et al. | β | 2021 | β |
| Differentiation reveals latent features of aging and an energy barrier in murine myogenesis. | Kimmel JC et al. | β | 2021 | β |
| Direct Conversion of Human Fibroblasts to Induced Neurons. | Zhou-Yang L et al. | β | 2021 | β |
| Directly converted astrocytes retain the ageing features of the donor fibroblasts and elucidate the astrocytic contribution to human CNS health and disease. | Gatto N et al. | β | 2021 | β |
| Directly Reprogrammed Human Neurons to Understand Age-Related Energy Metabolism Impairment and Mitochondrial Dysfunction in Healthy Aging and Neurodegeneration. | Gudenschwager C et al. | β | 2021 | β |
| Directly reprogrammed Huntington's disease neural precursor cells generate striatal neurons exhibiting aggregates and impaired neuronal maturation. | Monk R et al. | β | 2021 | β |
| Directly Reprogrammed Neurons Express MAPT and APP Splice Variants Pertinent to Ageing and Neurodegeneration. | Habekost M et al. | β | 2021 | β |
| Direct Neuronal Reprogramming: Bridging the Gap Between Basic Science and Clinical Application. | Vasan L et al. | β | 2021 | β |
| Direct Reprogramming of Fibroblasts to Astrocytes Using Small Molecules. | Tian E et al. | β | 2021 | β |
| Direct Reprogramming of Somatic Cells to Neurons: Pros and Cons of Chemical Approach. | Mollinari C et al. | β | 2021 | β |
| Disease Modeling with Human Neurons Reveals LMNB1 Dysregulation Underlying DYT1 Dystonia. | Ding B et al. | β | 2021 | β |
| Dissecting Alzheimer's disease pathogenesis in human 2D and 3D models. | Cenini G et al. | β | 2021 | β |
| Dopamine Neuron Diversity: Recent Advances and Current Challenges in Human Stem Cell Models and Single Cell Sequencing. | Fiorenzano A et al. | β | 2021 | β |
| Dysregulation of PGC-1Ξ±-Dependent Transcriptional Programs in Neurological and Developmental Disorders: Therapeutic Challenges and Opportunities. | McMeekin LJ et al. | β | 2021 | β |
| Editorial: Stem Cells in Neurodegeneration: Disease Modeling and Therapeutics. | Staats KA | β | 2021 | β |
| Emerging hiPSC Models for Drug Discovery in Neurodegenerative Diseases. | Trudler D et al. | β | 2021 | β |
| Evidence of the Cellular Senescence Stress Response in Mitotically Active Brain Cells-Implications for Cancer and Neurodegeneration. | Gillispie GJ et al. | β | 2021 | β |
| From Brain Organoids to Networking Assembloids: Implications for Neuroendocrinology and Stress Medicine. | Makrygianni EA et al. | β | 2021 | β |
| Generation of Human Neurons by microRNA-Mediated Direct Conversion of Dermal Fibroblasts. | Church VA et al. | β | 2021 | β |
| Generation of Induced Dopaminergic Neurons from Human Fetal Fibroblasts. | Legault EM et al. | β | 2021 | β |
| hnRNP A1B, a Splice Variant of <i>HNRNPA1</i>, Is Spatially and Temporally Regulated. | GagnΓ© M et al. | β | 2021 | β |
| Human iPSC-Based Modeling of Central Nerve System Disorders for Drug Discovery. | Qian L et al. | β | 2021 | β |
| Human iPSC-Derived Neurons as A Platform for Deciphering the Mechanisms behind Brain Aging. | Chao CC et al. | β | 2021 | β |
| Hypothesis and Theory: Characterizing Abnormalities of Energy Metabolism Using a Cellular Platform as a Personalized Medicine Approach for Alzheimer's Disease. | Ryu WI et al. | β | 2021 | β |
| Identification of conserved transcriptome features between humans and Drosophila in the aging brain utilizing machine learning on combined data from the NIH Sequence Read Archive. | Webb JL et al. | β | 2021 | β |
| Improved Method for Efficient Generation of Functional Neurons from Murine Neural Progenitor Cells. | Soni A et al. | β | 2021 | β |
| Induced Neurons for Disease Modeling and Repair: A Focus on Non-fibroblastic Cell Sources in Direct Reprogramming. | Kim KM et al. | β | 2021 | β |
| Inflammation, epigenetics, and metabolism converge to cell senescence and ageing: the regulation and intervention. | Zhu X et al. | β | 2021 | β |
| Interactions between ALS-linked FUS and nucleoporins are associated with defects in the nucleocytoplasmic transport pathway. | Lin YC et al. | β | 2021 | β |
| Lamin B1 decline underlies age-related loss of adult hippocampal neurogenesis. | Bedrosian TA et al. | β | 2021 | β |
| Leigh Syndrome: A Tale of Two Genomes. | Bakare AB et al. | β | 2021 | β |
| Long-term culture of SH-SY5Y neuroblastoma cells in the absence of neurotrophins: A novel model of neuronal ageing. | Strother L et al. | β | 2021 | β |
| Mass spectrometry analysis of tau and amyloid-beta in iPSC-derived models of Alzheimer's disease and dementia. | Arber C et al. | β | 2021 | β |
| Multifaceted involvement of microglia in gray matter pathology in multiple sclerosis. | Tsouki F et al. | β | 2021 | β |
| Mutant Presenilin 1 Dysregulates Exosomal Proteome Cargo Produced by Human-Induced Pluripotent Stem Cell Neurons. | Podvin S et al. | β | 2021 | β |
| Neuromuscular junction-on-a-chip: ALS disease modeling and read-out development in microfluidic devices. | de Jongh R et al. | β | 2021 | β |
| Novel epigenetic clock for fetal brain development predicts prenatal age for cellular stem cell models and derived neurons. | Steg LC et al. | β | 2021 | β |
| Nuclear lamina invaginations are not a pathological feature of C9orf72 ALS/FTD. | Coyne AN et al. | β | 2021 | β |
| Nucleocytoplasmic Transport: Regulatory Mechanisms and the Implications in Neurodegeneration. | Ding B et al. | β | 2021 | β |
| One-step Reprogramming of Human Fibroblasts into Oligodendrocyte-like Cells by SOX10, OLIG2, and NKX6.2. | Chanoumidou K et al. | β | 2021 | β |
| Opportunities and Challenges in Stem Cell Aging. | Larijani B et al. | β | 2021 | β |
| Pathologic tau conformer ensembles induce dynamic, liquid-liquid phase separation events at the nuclear envelope. | Kang SG et al. | β | 2021 | β |
| Persistent DNA damage alters the neuronal transcriptome suggesting cell cycle dysregulation and altered mitochondrial function. | Vazquez-Villasenor I et al. | β | 2021 | β |
| [Pharmacological studies using iPSC-derived neurons from patients with schizophrenia]. | Nakazawa T | β | 2021 | β |
| Regenerative medicine for neurological diseases-will regenerative neurosurgery deliver? | Burns TC et al. | β | 2021 | β |
| Reprogrammed Synovial Fluid-Derived Mesenchymal Stem/Stromal Cells Acquire Enhanced Therapeutic Potential for Articular Cartilage Repair. | Walczak BE et al. | β | 2021 | β |
| Reprogramming Human Adult Fibroblasts into GABAergic Interneurons. | Bruzelius A et al. | β | 2021 | β |
| Stem Cell-Based Therapies: What Interventional Radiologists Need to Know. | Yu H et al. | β | 2021 | β |
| The application of in vitro-derived human neurons in neurodegenerative disease modeling. | D'Souza GX et al. | β | 2021 | β |
| The Danaid Theory of Aging. | Wensink MJ et al. | β | 2021 | β |
| The Role of Nucleocytoplasmic Transport Defects in Amyotrophic Lateral Sclerosis. | Vanneste J et al. | β | 2021 | β |
| UTX maintains the functional integrity of the murine hematopoietic system by globally regulating aging-associated genes. | Sera Y et al. | β | 2021 | β |
| A decade of questions about the fluidity of cell identity. | Masserdotti G et al. | β | 2020 | β |
| Advances in mt-tRNA Mutation-Caused Mitochondrial Disease Modeling: Patients' Brain in a Dish. | Povea-Cabello S et al. | β | 2020 | β |
| Aging-relevant human basal forebrain cholinergic neurons as a cell model for Alzheimer's disease. | Ma S et al. | β | 2020 | β |
| A Physiological Instability Displayed in Hippocampal Neurons Derived From Lithium-Nonresponsive Bipolar Disorder Patients. | Stern S et al. | β | 2020 | β |
| Cell Reprogramming Preserving Epigenetic Age: Advantages and Limitations. | Samoylova EM et al. | β | 2020 | β |
| Characterizing the nuclear and cytoplasmic transcriptomes in developing and mature human cortex uncovers new insight into psychiatric disease gene regulation. | Price AJ et al. | β | 2020 | β |
| Copy number variants (CNVs): a powerful tool for iPSC-based modelling of ASD. | Drakulic D et al. | β | 2020 | β |
| CRISPR-based functional evaluation of schizophrenia risk variants. | Rajarajan P et al. | β | 2020 | β |
| CRISPR-based functional genomics for neurological disease. | Kampmann M | β | 2020 | β |
| Decoding the relationship between ageing and amyotrophic lateral sclerosis: a cellular perspective. | Pandya VA et al. | β | 2020 | β |
| Deficits in Mitochondrial Spare Respiratory Capacity Contribute to the Neuropsychological Changes of Alzheimer's Disease. | Bell SM et al. | β | 2020 | β |
| Differential Influence of Sample Sex and Neuronal Maturation on mRNA and Protein Transport in Induced Human Neurons. | Ding B et al. | β | 2020 | β |
| Direct conversion of human fibroblasts into therapeutically active vascular wall-typical mesenchymal stem cells. | Steens J et al. | β | 2020 | β |
| Direct reprogramming of human smooth muscle and vascular endothelial cells reveals defects associated with aging and Hutchinson-Gilford progeria syndrome. | Bersini S et al. | β | 2020 | β |
| Engineering Biomaterials with Micro/Nanotechnologies for Cell Reprogramming. | Fang J et al. | β | 2020 | β |
| Functional genomics, genetic risk profiling and cell phenotypes in neurodegenerative disease. | Finkbeiner S | β | 2020 | β |
| How can aging be reversed? Exploring rejuvenation from a damage-based perspective. | Zhang B et al. | β | 2020 | β |
| How to reprogram human fibroblasts to neurons. | Xu Z et al. | β | 2020 | β |
| Human Autopsy-Derived Scalp Fibroblast Biobanking for Age-Related Neurodegenerative Disease Research. | Beh ST et al. | β | 2020 | β |
| Human Induced Pluripotent Stem Cell Models of Neurodegenerative Disorders for Studying the Biomedical Implications of Autophagy. | Seranova E et al. | β | 2020 | β |
| Human-induced pluripotent stem cells as a model for studying sporadic Alzheimer's disease. | Riemens RJM et al. | β | 2020 | β |
| Human in vitro models for understanding mechanisms of autism spectrum disorder. | Gordon A et al. | β | 2020 | β |
| Human pluripotent stem cell-derived models and drug screening in CNS precision medicine. | Silva MC et al. | β | 2020 | β |
| Huntington's Disease Pathogenesis Is Modified InΒ Vivo by Alfy/Wdfy3 and Selective Macroautophagy. | Fox LM et al. | β | 2020 | β |
| Innovations in 3-Dimensional Tissue Models of Human Brain Physiology and Diseases. | Lovett ML et al. | β | 2020 | β |
| Integrating CRISPR Engineering and hiPSC-Derived 2D Disease Modeling Systems. | Rehbach K et al. | β | 2020 | β |
| Mechanisms Underlying the Hyperexcitability of CA3 and Dentate Gyrus Hippocampal Neurons Derived From Patients With Bipolar Disorder. | Stern S et al. | β | 2020 | β |
| Microglia: Agents of the CNS Pro-Inflammatory Response. | RodrΓguez-GΓ³mez JA et al. | β | 2020 | β |
| MicroRNAs and Ascl1 facilitate direct conversion of porcine fibroblasts into induced neurons. | Habekost M et al. | β | 2020 | β |
| Modeling Alzheimer's disease with iPSC-derived brain cells. | Penney J et al. | β | 2020 | β |
| Modeling cell-autonomous motor neuron phenotypes in ALS using iPSCs. | Hawrot J et al. | β | 2020 | β |
| Modelling frontotemporal dementia using patient-derived induced pluripotent stem cells. | Lines G et al. | β | 2020 | β |
| Neurodegeneration in a dish: advancing human stem-cell-based models of Alzheimer's disease. | Klimmt J et al. | β | 2020 | β |
| Neurogenic Niche Conversion Strategy Induces Migration and Functional Neuronal Differentiation of Neural Precursor Cells Following Brain Injury. | Wang Z et al. | β | 2020 | β |
| Neuronal Trans-differentiation by Transcription Factors Ascl1 and Nurr1: Induction of a Dopaminergic Neurotransmitter Phenotype in Cortical GABAergic Neurons. | Raina A et al. | β | 2020 | β |
| Neuroprotective Effects of Cryptotanshinone in a Direct Reprogramming Model of Parkinson's Disease. | Lee JE et al. | β | 2020 | β |
| Nuclear Import Receptors Directly Bind to Arginine-Rich Dipeptide Repeat Proteins and Suppress Their Pathological Interactions. | Hutten S et al. | β | 2020 | β |
| Nuclear Periphery Takes Center Stage: The Role of Nuclear Pore Complexes in Cell Identity and Aging. | Cho UH et al. | β | 2020 | β |
| Nuclear Transport Deficits in Tau-Related Neurodegenerative Diseases. | Diez L et al. | β | 2020 | β |
| Nucleo-cytoplasmic transport defects and protein aggregates in neurodegeneration. | Bitetto G et al. | β | 2020 | β |
| Nucleocytoplasmic transport defects in neurodegeneration - Cause or consequence? | Hutten S et al. | β | 2020 | β |
| Optical induction of autophagy via Transcription factor EB (TFEB) reduces pathological tau in neurons. | Binder JL et al. | β | 2020 | β |
| Parkinson's disease-related Leucine-rich repeat kinase 2 modulates nuclear morphology and genomic stability in striatal projection neurons during aging. | Chen X et al. | β | 2020 | β |
| Precision Medicine in Rare Diseases. | VillalΓ³n-GarcΓa I et al. | β | 2020 | β |
| Prospects of Directly Reprogrammed Adult Human Neurons for Neurodegenerative Disease Modeling and Drug Discovery: iN vs. iPSCs Models. | Zhang Y et al. | β | 2020 | β |
| Reprogramming to recover youthful epigenetic information and restore vision. | Lu Y et al. | β | 2020 | β |
| Skeletal muscle as an experimental model of choice to study tissue aging and rejuvenation. | Etienne J et al. | β | 2020 | β |
| Stem Cells of the Aging Brain. | Nicaise AM et al. | β | 2020 | β |
| Stress-Specific Spatiotemporal Responses of RNA-Binding Proteins in Human Stem-Cell-Derived Motor Neurons. | Harley J et al. | β | 2020 | β |
| The eroding chromatin landscape of aging stem cells. | Shi C et al. | β | 2020 | β |
| The iNs and Outs of Direct Reprogramming to Induced Neurons. | Carter JL et al. | β | 2020 | β |
| The Rise of Retinal Organoids for Vision Research. | Sharma K et al. | β | 2020 | β |
| Three-dimensional modeling of human neurodegeneration: brain organoids coming of age. | Grenier K et al. | β | 2020 | β |
| Toward Generating Subtype-Specific Mesencephalic Dopaminergic Neurons <i>in vitro</i>. | Cardoso T et al. | β | 2020 | β |
| Traffic jam at the nuclear pore: All roads lead to nucleocytoplasmic transport defects in ALS/FTD. | Fallini C et al. | β | 2020 | β |
| Transcriptional and Functional Changes of the Human Microvasculature during Physiological Aging and Alzheimer Disease. | Bersini S et al. | β | 2020 | β |
| Transcription Factor-Based Fate Specification and Forward Programming for Neural Regeneration. | Flitsch LJ et al. | β | 2020 | β |
| Transient non-integrative expression of nuclear reprogramming factors promotes multifaceted amelioration of aging in human cells. | Sarkar TJ et al. | β | 2020 | β |
| Understanding metabolic flexibility: a potential key to unlocking metabolic therapies in amyotrophic lateral sclerosis? | Allen SP | β | 2020 | β |
| Using human induced pluripotent stem cells (hiPSCs) to investigate the mechanisms by which Apolipoprotein E (APOE) contributes to Alzheimer's disease (AD) risk. | Raman S et al. | β | 2020 | β |
| What electrophysiology tells us about Alzheimer's disease: a window into the synchronization and connectivity of brain neurons. | Babiloni C et al. | β | 2020 | β |
| When function follows form: Nuclear compartment structure and the epigenetic landscape of the aging neuron. | Schlachetzki JCM et al. | β | 2020 | β |
| A Comprehensive Resource for Induced Pluripotent Stem Cells from Patients with Primary Tauopathies. | Karch CM et al. | β | 2019 | β |
| Aging: A cell source limiting factor in tissue engineering. | Khorraminejad-Shirazi M et al. | β | 2019 | β |
| A High-throughput and Pathophysiologically Relevant Astrocyte-motor Neuron Co-culture Assay for Amyotrophic Lateral Sclerosis Therapeutic Discovery. | Stopford MJ et al. | β | 2019 | β |
| Alcohol-responsive genes identified in human iPSC-derived neural cultures. | Jensen KP et al. | β | 2019 | β |
| Alzheimer's in a dish - induced pluripotent stem cell-based disease modeling. | de Leeuw S et al. | β | 2019 | β |
| A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer's disease brain. | Ercan-Herbst E et al. | β | 2019 | β |
| Application of Urine-Derived Stem Cells to Cellular Modeling in Neuromuscular and Neurodegenerative Diseases. | Sato M et al. | β | 2019 | β |
| Are There Common Mechanisms Between the Hutchinson-Gilford Progeria Syndrome and Natural Aging? | Ashapkin VV et al. | β | 2019 | β |
| Biomolecular condensates in neurodegeneration and cancer. | Spannl S et al. | β | 2019 | β |
| BrainImageR: spatiotemporal gene set analysis referencing the human brain. | Linker SB et al. | β | 2019 | β |
| Chemical modulation of transcriptionally enriched signaling pathways to optimize the conversion of fibroblasts into neurons. | Herdy J et al. | β | 2019 | β |
| Chromatin establishes an immature version of neuronal protocadherin selection during the naive-to-primed conversion of pluripotent stem cells. | Almenar-Queralt A et al. | β | 2019 | β |
| Coaching from the sidelines: the nuclear periphery in genome regulation. | Buchwalter A et al. | β | 2019 | β |
| Comparison of three congruent patient-specific cell types for the modelling of a human genetic Schwann-cell disorder. | Mukherjee-Clavin B et al. | β | 2019 | β |
| Contribution of induced pluripotent stem cell technologies to the understanding of cellular phenotypes in schizophrenia. | Balan S et al. | β | 2019 | β |
| Current Challenges of iPSC-Based Disease Modeling and Therapeutic Implications. | Doss MX et al. | β | 2019 | β |
| Cytoplasmic TDP-43 De-mixing Independent of Stress Granules Drives Inhibition of Nuclear Import, Loss of Nuclear TDP-43, and Cell Death. | Gasset-Rosa F et al. | β | 2019 | β |
| Direct reprogramming into interneurons: potential for brain repair. | Pereira M et al. | β | 2019 | β |
| Dual modulation of neuron-specific microRNAs and the REST complex promotes functional maturation of human adult induced neurons. | Birtele M et al. | β | 2019 | β |
| Early Actions of Neurotransmitters During Cortex Development and Maturation of Reprogrammed Neurons. | Ojeda J et al. | β | 2019 | β |
| Epigenetic Age Reversal by Cell-Extrinsic and Cell-Intrinsic Means. | Mendelsohn AR et al. | β | 2019 | β |
| Epigenetic Analysis in Human Neurons: Considerations for Disease Modeling in PD. | de Boni L et al. | β | 2019 | β |
| Epigenetic changes during aging and their reprogramming potential. | Kane AE et al. | β | 2019 | β |
| Evolving principles underlying neural lineage conversion and their relevance for biomedical translation. | Flitsch LJ et al. | β | 2019 | β |
| Functional maturation of human neural stem cells in a 3D bioengineered brain model enriched with fetal brain-derived matrix. | Sood D et al. | β | 2019 | β |
| Harnessing cellular aging in human stem cell models of amyotrophic lateral sclerosis. | Ziff OJ et al. | β | 2019 | β |
| Heterogeneity in old fibroblasts is linked to variability in reprogramming and wound healing. | Mahmoudi S et al. | β | 2019 | β |
| Human iPSC application in Alzheimer's disease and Tau-related neurodegenerative diseases. | Tcw J | β | 2019 | β |
| Human Stem Cell-Derived Models: Lessons for Autoimmune Diseases of the Nervous System. | Harschnitz O | β | 2019 | β |
| Human stem cell-derived monocytes and microglia-like cells reveal impaired amyloid plaque clearance upon heterozygous or homozygous loss of TREM2. | Claes C et al. | β | 2019 | β |
| Induced pluripotent stem cell-based modeling of mutant LRRK2-associated Parkinson's disease. | Weykopf B et al. | β | 2019 | β |
| Live-Imaging Readouts and Cell Models for Phenotypic Profiling of Mitochondrial Function. | Iannetti EF et al. | β | 2019 | β |
| LncRNAs regulating stemness in aging. | Sousa-Franco A et al. | β | 2019 | β |
| MicroRNAs and the Genetic Nexus of Brain Aging, Neuroinflammation, Neurodegeneration, and Brain Trauma. | Sarkar SN et al. | β | 2019 | β |
| Microtubules Deform the Nuclear Membrane and Disrupt Nucleocytoplasmic Transport in Tau-Mediated Frontotemporal Dementia. | Paonessa F et al. | β | 2019 | β |
| Modeling Alzheimer's disease with human iPS cells: advancements, lessons, and applications. | Essayan-Perez S et al. | β | 2019 | β |
| Modeling Cell-Cell Interactions in Parkinson's Disease Using Human Stem Cell-Based Models. | Simmnacher K et al. | β | 2019 | β |
| Modelling mitochondrial dysfunction in Alzheimer's disease using human induced pluripotent stem cells. | Hawkins KE et al. | β | 2019 | β |
| Multiplication of the SNCA locus exacerbates neuronal nuclear aging. | Tagliafierro L et al. | β | 2019 | β |
| Next-generation disease modeling with direct conversion: a new path to old neurons. | Traxler L et al. | β | 2019 | β |
| Non-engineered and Engineered Adult Neurogenesis in Mammalian Brains. | Lei W et al. | β | 2019 | β |
| Partial Reprogramming As An Emerging Strategy for Safe Induced Cell Generation and Rejuvenation. | Lehmann M et al. | β | 2019 | β |
| Periodontal Ligament Stem Cells: Regenerative Potency in Periodontium. | Tomokiyo A et al. | β | 2019 | β |
| Pharmacological Transdifferentiation of Human Nasal Olfactory Stem Cells into Dopaminergic Neurons. | Chabrat A et al. | β | 2019 | β |
| Precision medicine in pantothenate kinase-associated neurodegeneration. | Alvarez-Cordoba M et al. | β | 2019 | β |
| Progress in understanding Friedreich's ataxia using human induced pluripotent stem cells. | Schreiber AM et al. | β | 2019 | β |
| REST and Neural Gene Network Dysregulation in iPSC Models of Alzheimer's Disease. | Meyer K et al. | β | 2019 | β |
| Reversibility of irreversible aging. | Galkin F et al. | β | 2019 | β |
| Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models. | Logan S et al. | β | 2019 | β |
| Temporal Control of Axonal Transport: The Extreme Case of Organismal Ageing. | Mattedi F et al. | β | 2019 | β |
| The Convergence of Stem Cell Technologies and Phenotypic Drug Discovery. | Friese A et al. | β | 2019 | β |
| The Link Between Epigenetic Clocks for Aging and Senescence. | Wagner W | β | 2019 | β |
| Therapeutic Dissolution of Aberrant Phases by Nuclear-Import Receptors. | Guo L et al. | β | 2019 | β |
| Transcriptional profiling of isogenic Friedreich ataxia neurons and effect of an HDAC inhibitor on disease signatures. | Lai JI et al. | β | 2019 | β |
| Turning back time with emerging rejuvenation strategies. | Mahmoudi S et al. | β | 2019 | β |
| Using human stem cells as a model system to understand the neural mechanisms of alcohol use disorders: Current status and outlook. | Scarnati MS et al. | β | 2019 | β |
| Visualization of long-lived proteins reveals age mosaicism within nuclei of postmitotic cells. | Toyama BH et al. | β | 2019 | β |
| Abnormal RNA stability in amyotrophic lateral sclerosis. | Tank EM et al. | β | 2018 | β |
| Age of donor of human mesenchymal stem cells affects structural and functional recovery after cell therapy following ischaemic stroke. | Yamaguchi S et al. | β | 2018 | β |
| Aging in a Dish: iPSC-Derived and Directly Induced Neurons for Studying Brain Aging and Age-Related Neurodegenerative Diseases. | Mertens J et al. | β | 2018 | β |
| An Overview of <i>in vitro</i> Methods to Study Microglia. | Timmerman R et al. | β | 2018 | β |
| A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation. | Sheng C et al. | β | 2018 | β |
| Best Practices for Translational Disease Modeling Using Human iPSC-Derived Neurons. | Engle SJ et al. | β | 2018 | β |
| Building Models of Brain Disorders with Three-Dimensional Organoids. | Amin ND et al. | β | 2018 | β |
| Cellular Models: HD Patient-Derived Pluripotent Stem Cells. | Geater C et al. | β | 2018 | β |
| Chemical compound-based direct reprogramming for future clinical applications. | Takeda Y et al. | β | 2018 | β |
| Comparative genomic analysis of embryonic, lineage-converted and stem cell-derived motor neurons. | Ichida JK et al. | β | 2018 | β |
| Concise Review: The Cellular Conspiracy of Amyotrophic Lateral Sclerosis. | Serio A et al. | β | 2018 | β |
| Directing neuronal cell fate in vitro: Achievements and challenges. | Riemens RJM et al. | β | 2018 | β |
| Elixir of Life: Thwarting Aging With Regenerative Reprogramming. | Beyret E et al. | β | 2018 | β |
| Facing up to the global challenges of ageing. | Partridge L et al. | β | 2018 | β |
| Genetics of Alcohol Use Disorder: A Role for Induced Pluripotent Stem Cells? | Prytkova I et al. | β | 2018 | β |
| Human Cortical Neuron Generation Using Cell Reprogramming: A Review of Recent Advances. | McCaughey-Chapman A et al. | β | 2018 | β |
| Human neurons to model aging: A dish best served old. | BΓΆhnke L et al. | β | 2018 | β |
| Huntington modeling improves with age. | Mattis VB et al. | β | 2018 | β |
| iPS cells in the study of PD molecular pathogenesis. | Cobb MM et al. | β | 2018 | β |
| iPSC Modeling of Presenilin1 Mutation in Alzheimer's Disease with Cerebellar Ataxia. | Li L et al. | β | 2018 | β |
| iPSCs from a Hibernator Provide a Platform for Studying Cold Adaptation and Its Potential Medical Applications. | Ou J et al. | β | 2018 | β |
| Leptomeninges-Derived Induced Pluripotent Stem Cells and Directly Converted Neurons From Autopsy Cases With Varying Neuropathologic Backgrounds. | Rose SE et al. | β | 2018 | β |
| Long Non-Coding RNAs in Neuronal Aging. | Pereira Fernandes D et al. | β | 2018 | β |
| Mechanisms of dietary flavonoid action in neuronal function and neuroinflammation. | Jaeger BN et al. | β | 2018 | β |
| Mechanistic Insights Into MicroRNA-Induced Neuronal Reprogramming of Human Adult Fibroblasts. | Lu YL et al. | β | 2018 | β |
| Mitochondrial Aging Defects Emerge in Directly Reprogrammed Human Neurons due to Their Metabolic Profile. | Kim Y et al. | β | 2018 | β |
| Modelling Sporadic Alzheimer's Disease Using Induced Pluripotent Stem Cells. | Rowland HA et al. | β | 2018 | β |
| Neural stem cells: developmental mechanisms and disease modeling. | Zhao X et al. | β | 2018 | β |
| Opportunities for organoids as new models of aging. | Hu JL et al. | β | 2018 | β |
| Parkinson's disease: what the model systems have taught us so far. | Ghatak S et al. | β | 2018 | β |
| Patient-Derived Induced Pluripotent Stem Cells and Organoids for Modeling Alpha Synuclein Propagation in Parkinson's Disease. | Koh YH et al. | β | 2018 | β |
| Pluripotent Stem Cells for Uncovering the Role of Mitochondria in Human Brain Function and Dysfunction. | Zink A et al. | β | 2018 | β |
| Predicting age from the transcriptome of human dermal fibroblasts. | Fleischer JG et al. | β | 2018 | β |
| Regenerative Approaches in Huntington's Disease: From Mechanistic Insights to Therapeutic Protocols. | Sassone J et al. | β | 2018 | β |
| Rejuvenation by cell reprogramming: a new horizon in gerontology. | Goya RG et al. | β | 2018 | β |
| Representing Diversity in the Dish: Using Patient-Derived <i>in Vitro</i> Models to Recreate the Heterogeneity of Neurological Disease. | Ghaffari LT et al. | β | 2018 | β |
| Reprogramming Glia Into Neurons in the Peripheral Auditory System as a Solution for Sensorineural Hearing Loss: Lessons From the Central Nervous System. | Meas SJ et al. | β | 2018 | β |
| RNA Degradation in Neurodegenerative Disease. | Weskamp K et al. | β | 2018 | β |
| Simple Generation of a High Yield Culture of Induced Neurons from Human Adult Skin Fibroblasts. | Shrigley S et al. | β | 2018 | β |
| Single-cell genomics to guide human stem cell and tissue engineering. | Camp JG et al. | β | 2018 | β |
| Sporadic Parkinson's disease derived neuronal cells show disease-specific mRNA and small RNA signatures with abundant deregulation of piRNAs. | Schulze M et al. | β | 2018 | β |
| Striatal neurons directly converted from Huntington's disease patient fibroblasts recapitulate age-associated disease phenotypes. | Victor MB et al. | β | 2018 | β |
| Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer's Disease. | Eftekharzadeh B et al. | β | 2018 | β |
| TDP43 nuclear export and neurodegeneration in models of amyotrophic lateral sclerosis and frontotemporal dementia. | Archbold HC et al. | β | 2018 | β |
| The effect of age on stem cell function and utility for therapy. | Narbonne P | β | 2018 | β |
| The effects of the TOMM40 poly-T alleles on Alzheimer's disease phenotypes. | Chiba-Falek O et al. | β | 2018 | β |
| The Therapeutic Potential of Metformin in Neurodegenerative Diseases. | Rotermund C et al. | β | 2018 | β |
| Transdifferentiation of Human Circulating Monocytes Into Neuronal-Like Cells in 20 Days and Without Reprograming. | Bellon A et al. | β | 2018 | β |
| Unveiling epigenetic regulation in cancer, aging, and rejuvenation with inΒ vivo reprogramming technology. | Sogabe Y et al. | β | 2018 | β |
| Altered neurite morphology and cholinergic function of induced pluripotent stem cell-derived neurons from a patient with Kleefstra syndrome and autism. | Nagy J et al. | β | 2017 | β |
| An update on stem cell biology and engineering for brain development. | Parr CJC et al. | β | 2017 | β |
| Brain repair from intrinsic cell sources: Turning reactive glia into neurons. | Torper O et al. | β | 2017 | β |
| Cell reprogramming: Therapeutic potential and the promise of rejuvenation for the aging brain. | LΓ³pez-LeΓ³n M et al. | β | 2017 | β |
| Clonal reversal of ageing-associated stem cell lineage bias via a pluripotent intermediate. | Wahlestedt M et al. | β | 2017 | β |
| Comprehensive investigation of temporal and autism-associated cell type composition-dependent and independent gene expression changes in human brains. | Yu Q et al. | β | 2017 | β |
| Concise Review: Induced Pluripotent Stem Cell-Based Drug Discovery for Mitochondrial Disease. | Inak G et al. | β | 2017 | β |
| Concise Review: Induced Pluripotent Stem Cell Models for Neuropsychiatric Diseases. | Adegbola A et al. | β | 2017 | β |
| Current Advances and Limitations in Modeling ALS/FTD in a Dish Using Induced Pluripotent Stem Cells. | Guo W et al. | β | 2017 | β |
| Direct Conversion Through Trans-Differentiation: Efficacy and Safety. | Prasad A et al. | β | 2017 | β |
| Direct Neuronal Reprogramming: Achievements, Hurdles, and New Roads to Success. | GascΓ³n S et al. | β | 2017 | β |
| Direct Neuronal Reprogramming for Disease Modeling Studies Using Patient-Derived Neurons: What Have We Learned? | Drouin-Ouellet J et al. | β | 2017 | β |
| Direct Reprogramming Rather than iPSC-Based Reprogramming Maintains Aging Hallmarks in Human Motor Neurons. | Tang Y et al. | β | 2017 | β |
| Drug discovery using induced pluripotent stem cell models of neurodegenerative and ocular diseases. | Hung SSC et al. | β | 2017 | β |
| Engineering kidney cells: reprogramming and directed differentiation to renal tissues. | Kaminski MM et al. | β | 2017 | β |
| Epigenetic Drift Is a Determinant of Mammalian Lifespan. | Mendelsohn AR et al. | β | 2017 | β |
| Escape from Pluripotency via Inhibition of TGF-Ξ²/BMP and Activation of Wnt Signaling Accelerates Differentiation and Aging in hPSC Progeny Cells. | Fujimori K et al. | β | 2017 | β |
| Examining FKBP5 mRNA expression in human iPSC-derived neural cells. | Lieberman R et al. | β | 2017 | β |
| From Stem Cell Research to Three-Dimensional Organoids and Their Applications in Cancer Research: Meeting Report on the 9th International Meeting of the Stem Cell Network North Rhine Westphalia. | Langer S et al. | β | 2017 | β |
| High content analysis in amyotrophic lateral sclerosis. | Rinaldi F et al. | β | 2017 | β |
| Human induced pluripotent stem cells as a research tool in Alzheimer's disease. | Robbins JP et al. | β | 2017 | β |
| Human induced pluripotent stem cells for modelling neurodevelopmental disorders. | Ardhanareeswaran K et al. | β | 2017 | β |
| Induced dopaminergic neurons: A new promise for Parkinson's disease. | Xu Z et al. | β | 2017 | β |
| Induced Pluripotent Stem Cell Neuronal Models for the Study of Autophagy Pathways in Human Neurodegenerative Disease. | JimΓ©nez-Moreno N et al. | β | 2017 | β |
| Induced pluripotent stem cell technology: a decade of progress. | Shi Y et al. | β | 2017 | β |
| Interpreting Gene Expression Effects of Disease-Associated Variants: A Lesson from <i>SNCA</i> rs356168. | Glenn OC et al. | β | 2017 | β |
| Lost in Transportation: Nucleocytoplasmic Transport Defects in ALS and Other Neurodegenerative Diseases. | Kim HJ et al. | β | 2017 | β |
| MicroRNAs Induce a Permissive Chromatin Environment that Enables Neuronal Subtype-Specific Reprogramming of Adult Human Fibroblasts. | Abernathy DG et al. | β | 2017 | β |
| Modeling schizophrenia pathogenesis using patient-derived induced pluripotent stem cells (iPSCs). | Noh H et al. | β | 2017 | β |
| Modeling tau pathology in human stem cell derived neurons. | Wray S | β | 2017 | β |
| Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis. | Nijssen J et al. | β | 2017 | β |
| Narcolepsy patients' blood-based miRNA expression profiling: miRNA expression differencesΒ with Pandemrix vaccination. | Mosakhani N et al. | β | 2017 | β |
| Nup153 Interacts with Sox2 to Enable Bimodal Gene Regulation and Maintenance of Neural Progenitor Cells. | Toda T et al. | β | 2017 | β |
| Polyglutamine-Expanded Huntingtin Exacerbates Age-Related Disruption of Nuclear Integrity and Nucleocytoplasmic Transport. | Gasset-Rosa F et al. | β | 2017 | β |
| Prospects for Modeling Abnormal Neuronal Function in Schizophrenia Using Human Induced Pluripotent Stem Cells. | Prytkova I et al. | β | 2017 | β |
| Rejuvenating Strategies for Stem Cell-Based Therapies in Aging. | Neves J et al. | β | 2017 | β |
| Rejuvenation by Partial Reprogramming of the Epigenome. | Mendelsohn AR et al. | β | 2017 | β |
| Reprogramming cells from Gulf War veterans into neurons to study Gulf War illness. | Qiang L et al. | β | 2017 | β |
| Reprogramming of somatic cells: iPS and iN cells. | Broccoli V | β | 2017 | β |
| REST suppression mediates neural conversion of adult human fibroblasts via microRNA-dependent and -independent pathways. | Drouin-Ouellet J et al. | β | 2017 | β |
| Stem cell models of Alzheimer's disease: progress and challenges. | Arber C et al. | β | 2017 | β |
| Stem Cells for Modeling and Therapy of Parkinson's Disease. | Zhang Q et al. | β | 2017 | β |
| Targeting Adult Neurogenesis to Optimize Hippocampal Circuits in Aging. | McAvoy KM et al. | β | 2017 | β |
| Testing the Amyloid Hypothesis with a Humanized AD Mouse Model. | Cahill MK et al. | β | 2017 | β |
| The role of epigenetics in renal ageing. | Shiels PG et al. | β | 2017 | β |
| The roles of the nuclear pore complex in cellular dysfunction, aging and disease. | Sakuma S et al. | β | 2017 | β |
| The slippery slope of hematopoietic stem cell aging. | Wahlestedt M et al. | β | 2017 | β |
| The translational potential of humanΒ induced pluripotent stem cells for clinical neurology : The translational potential of hiPSCs in neurology. | Devine H et al. | β | 2017 | β |
| TOR-mediated regulation of metabolism in aging. | Antikainen H et al. | β | 2017 | β |
| Understanding Parkinson's Disease through the Use of Cell Reprogramming. | Playne R et al. | β | 2017 | β |
| Using induced pluripotent stem cells to explore genetic and epigenetic variation associated with Alzheimer's disease. | Imm J et al. | β | 2017 | β |
| What have we learned on aging from omics studies? | Cellerino A et al. | β | 2017 | β |
| Aged and Diseased Neurons Get Lost in Transport. | Tamburrino A et al. | β | 2016 | β |
| ALS disrupts spinal motor neuron maturation and aging pathways within gene co-expression networks. | Ho R et al. | β | 2016 | β |
| Alzheimer disease research in the 21st century: past and current failures, new perspectives and funding priorities. | Pistollato F et al. | β | 2016 | β |
| Alzheimer's Disease Mechanisms and Emerging Roads to Novel Therapeutics. | Sala Frigerio C et al. | β | 2016 | β |
| Anti-Aging Strategies Based on Cellular Reprogramming. | Ocampo A et al. | β | 2016 | β |
| Are aberrant phase transitions a driver of cellular aging? | Alberti S et al. | β | 2016 | β |
| Complex Tissue and Disease Modeling using hiPSCs. | Passier R et al. | β | 2016 | β |
| Concise Review: Progress and Challenges in Using Human Stem Cells for Biological and Therapeutics Discovery: Neuropsychiatric Disorders. | Panchision DM | β | 2016 | β |
| Direct neuronal reprogramming: learning from and for development. | Masserdotti G et al. | β | 2016 | β |
| DNA methylation in Parkinson's disease. | WΓΌllner U et al. | β | 2016 | β |
| Engineering cell fate: Spotlight on cell-activation and signaling-directed lineage conversion. | Ebrahimi B | β | 2016 | β |
| Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience. | Mertens J et al. | β | 2016 | β |
| FoxO3 regulates neuronal reprogramming of cells from postnatal and aging mice. | Ahlenius H et al. | β | 2016 | β |
| Functional Properties of Human Stem Cell-Derived Neurons in Health and Disease. | Weick JP | β | 2016 | β |
| Human dermal fibroblasts in psychiatry research. | KΓ‘lmΓ‘n S et al. | β | 2016 | β |
| Human Stem Cell-Derived Astrocytes: Specification and Relevance for Neurological Disorders. | Tyzack G et al. | β | 2016 | β |
| Insights into the pathogenic mechanisms of Chromosome 9 open reading frame 72 (C9orf72) repeat expansions. | Todd TW et al. | β | 2016 | β |
| iPSCs: On the Road to Reprogramming Aging. | Soria-Valles C et al. | β | 2016 | β |
| Linking adult hippocampal neurogenesis with human physiology and disease. | Bowers M et al. | β | 2016 | β |
| Maintenance of age in human neurons generated by microRNA-based neuronal conversion of fibroblasts. | Huh CJ et al. | β | 2016 | β |
| Modeling ALS with motor neurons derived from human induced pluripotent stem cells. | Sances S et al. | β | 2016 | β |
| Molecular Obstacles to Clinical Translation of iPSCs. | Tapia N et al. | β | 2016 | β |
| Multitasking Microglia and Alzheimer's Disease: Diversity, Tools and Therapeutic Targets. | Grubman A et al. | β | 2016 | β |
| Neural Subtype Specification from Human Pluripotent Stem Cells. | Tao Y et al. | β | 2016 | β |
| New In Vitro Models to Study Amyotrophic Lateral Sclerosis. | Myszczynska M et al. | β | 2016 | β |
| Nuclear transport dysfunction: a common theme in amyotrophic lateral sclerosis and frontotemporal dementia. | JoviΔiΔ A et al. | β | 2016 | β |
| Poly(GR) in C9ORF72-Related ALS/FTD Compromises Mitochondrial Function and Increases Oxidative Stress and DNA Damage in iPSC-Derived Motor Neurons. | Lopez-Gonzalez R et al. | β | 2016 | β |
| Review: Induced pluripotent stem cell models of frontotemporal dementia. | Preza E et al. | β | 2016 | β |
| Small Molecules Modulate Chromatin Accessibility to Promote NEUROG2-Mediated Fibroblast-to-Neuron Reprogramming. | Smith DK et al. | β | 2016 | β |
| Stem cells for all ages, yet hostage to aging. | Finch CE et al. | β | 2016 | β |
| Study of mitochondrial respiratory defects on reprogramming to human induced pluripotent stem cells. | Hung SS et al. | β | 2016 | β |
| The Aging Epigenome. | Booth LN et al. | β | 2016 | β |
| Therapeutics from Adult Stem Cells and the Hype Curve. | Maguire G | β | 2016 | β |
| When stem cells grow old: phenotypes and mechanisms of stem cell aging. | Schultz MB et al. | β | 2016 | β |
| Direct Conversion Provides Old Neurons from Aged Donor's Skin. | Koch P | β | 2015 | β |